Skip to main content
. 2020 Jun 12;25:e922723-1–e922723-9. doi: 10.12659/AOT.922723

Supplementary Table 4.

Postoperative outcomes.

Patient Peak perioperative AST/ALT (U/L) Peak perioperative total bilirubin (mg/dL) AMR ACR Allograft vasculopathy Graft failure Death Survival Cause of death
1 None None No No Yes 2 days Unknown
2 None Yes Yes No Yes 18 years Metastatic colon cancer
3 None None No No Yes 1 day Tamponade, heart failure
4 75/145 1.1 None None Yes No Yes 7.5 years Heart failure
5 104/45 2.1 None None No No No
6 223/50 1.9 None None No No No
7 247/52 3.6 None None No No No
8 116/29 0.6 None None No No No
9 29/35 1 None None No No No
10 180/144 1.9 None None No No No

ACR – acute cellular rejection; ALT – alanine transferase; AMR – antibody-mediated rejection; AST – aspartate aminotransferase.